Back
Royalty Pharma PLC Vs. Pacira BioSciences Industry Stock Comparison
Sell
31
RPRX
Royalty Pharma PLC
Last Price:
27.26
Seasonality Move:
-2.02%
Buy
57
PCRX
Pacira BioSciences
Last Price:
30.79
Seasonality Move:
7.59%
Sell
31
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy, Sell or Hold?
- The current Royalty Pharma PLC [RPRX] share price is $27.27. The Score for RPRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Pacira BioSciences (PCRX)
is a Buy
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $30.82. The Score for PCRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RPRX Stock Price Chart
What is Royalty Pharma PLC's stock price today?
-
The Royalty Pharma PLC share price today is $27.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing selling pressure, which indicates risk of future bearish movement.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.
RPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 36.31 | Sell |
Chaikin Money Flow: | -1694297 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.71 - 28.35) | Sell |
Bollinger Bands (100): | (27.98 - 30.06) | Sell |
PCRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.86 | Buy |
Relative Strength Index (14 RSI): | 62.81 | Buy |
Chaikin Money Flow: | -360300 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.83 - 29.57) | Buy |
Bollinger Bands (100): | (27.58 - 32.1) | Buy |
RPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.98 | Sell |
20-day SMA: | 28.07 | Sell |
50-day SMA: | 28.92 | Sell |
200-day SMA: | 28.57 | Sell |
8-day EMA: | 27.92 | Sell |
20-day EMA: | 28.15 | Sell |
50-day EMA: | 28.59 | Sell |
200-day EMA: | 29.61 | Sell |
PCRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.32 | Buy |
20-day SMA: | 28 | Buy |
50-day SMA: | 28.39 | Buy |
200-day SMA: | 30.72 | Buy |
8-day EMA: | 30.06 | Buy |
20-day EMA: | 28.85 | Buy |
50-day EMA: | 28.63 | Buy |
200-day EMA: | 31.56 | Sell |
Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.20 per share, and an increase next year of $0.38 per share.
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.14 per share, and an increase next year of $0.80 per share.
Royalty Pharma PLC Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pacira BioSciences Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |